KATHMANDU, July 19: The government is set to launch the Johnson and Johnson vaccination campaign in all districts including the Kathmandu Valley from today.

July 13: Johnson & Johnson (JNJ.N) said on Monday it was in discussions with the U.S. Food and Drug Administration about rare cases of a neurological disorder, Guillain-Barré syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine.